Skip to main content

Defining the impact of chronic lung disease on COVID-19 and developing effective therapies

Project Member(s): Hansbro, N., Hansbro, P., Faiz, A., Idrees, S., Johansen, M., Saunders, B.

Funding or Partner Organisation: National Health & Medical Research Council (NHMRC - Ideas Grants)
National Health & Medical Research Council (NHMRC - Ideas Grants)

Start year: 2022

Summary: Patients with chronic illnesses, including chronic obstructive pulmonary disease (COPD), tuberculosis (TB) and cardiovascular disease, have increased predisposition to severe COVID-19 disease. We shall undertake an integrated series of experiments to understand how chronic lung disease increases susceptibility and severity of COVID-19, and how CoV2 infection exacerbates TB and COPD.

FOR Codes: Respiratory diseases , Prevention of human diseases and conditions